多发性硬化症患者琥珀酰胆碱诱发的高钾血症。
Succinylcholine-induced hyperkalemia in a patient with multiple sclerosis.
作者信息
Levine Michael, Brown David F M
机构信息
Department of Emergency Medicine, Section of Medical Toxicology, University of Southern California, Los Angeles, California 90033, USA.
出版信息
J Emerg Med. 2012 Aug;43(2):279-82. doi: 10.1016/j.jemermed.2011.06.062. Epub 2011 Dec 3.
BACKGROUND
Succinylcholine administration is associated with hyperkalemia in patients with a variety of medical conditions, including many neuromuscular disorders. Nonetheless, there is a paucity of literature describing hyperkalemia after the administration of succinylcholine to patients with multiple sclerosis.
CASE REPORT
This case report describes a 38-year-old woman with multiple sclerosis who developed life-threatening hyperkalemia after the administration of succinylcholine during rapid sequence intubation.
CONCLUSION
This case highlights the potential for iatrogenic hyperkalemia after succinylcholine in patients with neurologic diseases, including multiple sclerosis.
背景
在患有多种疾病（包括许多神经肌肉疾病）的患者中，使用琥珀酰胆碱与高钾血症有关。尽管如此，关于给多发性硬化症患者使用琥珀酰胆碱后发生高钾血症的文献却很少。
病例报告
本病例报告描述了一名38岁的多发性硬化症女性患者，在快速顺序诱导插管期间使用琥珀酰胆碱后发生了危及生命的高钾血症。
结论
本病例强调了在包括多发性硬化症在内的神经系统疾病患者中，使用琥珀酰胆碱后发生医源性高钾血症的可能性。
Zotero 插件